Saint Luke's Mid America Heart Institute

Twitter home of Mid America Heart Institute, St. Luke’s Hospital of Kansas City @saintlukeskc

[Saint Luke's Mid America Heart Institute @MidAmericaHeart]

Fellowship application season is upon us!

@UMKC and Saint Luke's @MidAmericaHeart offers:
✴️ 3 yr CV fellowship
✴️ 4 yr T32 clinical/research track
✴️ Advanced HF
✴️ EP
✴️ Interventional
✴️ Structural
✴️ CV Imaging
✴️ Prevention

Apply today!

https://t.co/7V9IO7eicX

[Saint Luke's Mid America Heart Institute @MidAmericaHeart]

Great opportunity!

[Saint Luke's Mid America Heart Institute @MidAmericaHeart]

Come join us!

@AndrewJSauer @jspertus @jamesokeefemd @akcmahi @chetanhuded @MichaelNassifMD @michaelleemain @erikahuttce @TimBateman6 @DeZorzi_MD @JAG24851 @DanyJacob87 @Lehenbauer_K @heartrct

https://t.co/8pxAa3oY2v

[Saint Luke's Mid America Heart Institute @MidAmericaHeart]

Come join us!

@AndrewJSauer @jspertus @jamesokeefemd @akcmahi @chetanhuded @MichaelNassifMD @michaelleemain @erikahuttce @TimBateman6 @DeZorzi_MD @JAG24851 @DanyJacob87 @Lehenbauer_K @heartrct

https://t.co/8pxAa3oY2v

[Saint Luke's Mid America Heart Institute @MidAmericaHeart]

Apply for Structural Intervention fellowship here!

Excellent opportunity to train at a high volume program.

[Saint Luke's @saintlukeskc]

The Cardiovascular Structural Intervention Fellowship through @UMKCMedSchool and @MidAmericaheart accepts one candidate per academic year. Fellows benefit from getting hands-on training from renowned specialists.

Learn more and request an application now: https://t.co/ZhEIgzthee

[Saint Luke's @saintlukeskc]

The Cardiovascular Structural Intervention Fellowship through @UMKCMedSchool and @MidAmericaheart accepts one candidate per academic year. Fellows benefit from getting hands-on training from renowned specialists.

Learn more and request an application now: https://t.co/ZhEIgzthee

[Saint Luke's Mid America Heart Institute @MidAmericaHeart]

Congratulations to Rich Liekweg, BJC Health System CEO, who announced his plans to retire on October 1, 2025.

BJC is pleased to announce that Nick Barto, current BJC Health System President, will succeed Rich as President and CEO of BJC Health System: https://t.co/wpXdGLElw2

[Brett Sperry, MD @BrettSperryMD]

Star fellow @mirzakhan_ presenting data on geographic patterns of prescriptions for amyloid medications from EPIC Cosmos at #ACC25

@MidAmericaHeart

[Andrew J Sauer MD @AndrewJSauer]

Understanding patient-reported outcomes in obstructive hypertrophic cardiomyopathy (oHCM) is vital for managing treatment effectively.

We recently validated the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) in this population. Here’s why it matters:

A quick🧵

https://t.co/I6AI4zSCkw

[Andrew J Sauer MD @AndrewJSauer]

At #ESCHF2025 🇷🇸 @MidAmericaHeart fellow Dr Omar Cantu-Martinez presents #CAREHKinHF real-world registry: >2,300 HF pts w/ hyperK risk with 9% on clinician selected patiromer.

Reduced severe HK and trend toward more optimal GDMT.

Take-home: early K⁺ control keeps GDMT on & protects heart + kidneys

[Andrew J Sauer MD @AndrewJSauer]

Grateful for the opportunity to work with @Amgen in collaboration with @cardiometalli @MidAmericaHeart as part of the LATTICE Consortium to address implementation of cardiometabolic therapies and stepping into the gaps.

[Brett Sperry, MD @BrettSperryMD]

Special focus issue in @JACCJournals this week on Cardiac Amyloidosis.

Many important articles! Sharing my editorial with Joban Vaishnav from @JohnsHopkins

https://t.co/Q2EBUABhw0

[CCF Cardiology Fellows @CCFcards]

One of the defining aspects of our fellowship are our accomplished alumni. As a part of our fellowship research day, Dr. Chhatriwalla honored us with a noon conference on advancements in ViV TAVR and bioprosthetic valve fracture! @akcmahi @venumenon10

[Saint Luke's Mid America Heart Institute @MidAmericaHeart]

Art Still, a former @Chiefs defensive end, has dedicated himself to increasing awareness for ATTR amyloidosis ever since his diagnosis in 2023.

@TODAYshow spoke with Dr. Brett Sperry, a @MidAmericaHeart cardiologist, to discuss the rare genetic condition: https://t.co/qbMKv9M20t

[Saint Luke's Mid America Heart Institute @MidAmericaHeart]

Outside of her work as an oncologist, Dr. Juliet Appiah helps cancer patients in her home country of Ghana.

Dr. Appiah spoke with @KSHB41 about her passion for giving back to her home country and raising awareness for all types of cancer. Watch now: https://t.co/GSMeSI9bm3

[Saint Luke's Mid America Heart Institute @MidAmericaHeart]

Here are some reasons why you should train with us in Cardiovascular Disease at the University of Missouri-Kansas City School of Medicine program @MidAmericaHeart @saintlukeskc!

[Andrew J Sauer MD @AndrewJSauer]

Proof I made it to @escardio

Let’s go!

Check out @JACCJournals publications our team is releasing soon during London sessions.

https://t.co/stkJGQKK1x

@MkosiborodMD
@jspertus
@MidAmericaHeart
@saintlukeskc

[Andrew J Sauer MD @AndrewJSauer]

Semaglutide and obesity related HFpEF

Patients with atrial fibrillation and obesity HFpEF are generally more burdened/congested at baseline and also may benefit more from GLP1 in health status and walking distance.

@MkosiborodMD
@MidAmericaHeart

https://t.co/Pd16sJe54A

[Andrew J Sauer MD @AndrewJSauer]

Inflammation reduction by semaglutide as measured by CRP tracks with magnitude of NTproBNP reduction.

[Andrew J Sauer MD @AndrewJSauer]

Semaglutide and obesity HFpEF

Echo markers

Improved LA volume reduction and markers of diastolic function with GLP1 compared to placebo.

@mvaduganathan
@BiykemB
@MkosiborodMD

[Andrew J Sauer MD @AndrewJSauer]

CV outcomes from FLOW trial.

Semaglutide vs placebo focused on patients with HF within larger population of T2DM and CKD.

[Andrew J Sauer MD @AndrewJSauer]

Pooled analysis of patients with HFpEF in STEP-HFpEF, SELECT, and FLOW

@MkosiborodMD
@MidAmericaHeart
@saintlukeskc
@mvaduganathan